RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Regenerative Medical Technology Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026
- Market cap
- $497.25K
- P/E (TTM)
- –
- Dividend yield
- –
Regenerative Medical Technology Group Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Stem Cells Group [Member] | $4.02M | $2.64M | $1.57M | $1.18M | – | – | – | – | – | – | – | – | 100.0% | – |
| Product supplies [Member] | $2.10M | $1.27M | $645.46K | $349.03K | $403.43K | $626.66K | $512.49K | $467.24K | $413.76K | $355.48K | $347.40K | $352.30K | 52.3% | +421.3% |
| Training [Member] | $1.30M | $772.01K | $466.68K | $378.96K | $134.97K | $144.92K | $408.86K | $132.97K | $157.49K | $110.33K | $137.15K | $170.81K | 32.2% | +859.9% |
| Patient procedures [Member] | $620.49K | $600.27K | $392.39K | $452.55K | $436.69K | $592.77K | $533.47K | $366.94K | $216.83K | $254.41K | $124.13K | $77.98K | 15.4% | +42.1% |
| Equipment [Member] | – | – | $67.40K | $0 | – | – | $56.00K | $19.17K | $5.25K | $96.81K | $6.89K | $45.74K | – | – |
By region
From the segment and revenue-disaggregation notes of Regenerative Medical Technology's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.